关于 "Reverse Transcriptase" 的结果4 个结果
筛选:JAK/STAT Signaling×
- Epertinib hydrochlorideCAS: 2071195-74-7
Epertinib hydrochloride (S-222611 hydrochloride) is a potent, orally active, reversible, and selective tyrosine kinase inhibitor of EGFR, HER2 and HER4 with IC50 of 1.48 nM, 7.15 nM and 2.49 nM, respectively. Epertinib hydrochloride (S-222611 hydrochloride) exhibits antitumor activity.
| 货号 | 产品名称 | CAS号 | 靶点 / 通路 | 引用 | 结构 |
|---|---|---|---|---|---|
| GC13761 | AZD8931 (Sapitinib) | 848942-61-0 | EGFR | ||
A reversible inhibitor of ErbB1/EGFR, ErbB2/HER2, and ErbB3/HER3 | |||||
| GC65436 | JND3229 | 2260886-64-2 | EGFR | ||
JND3229 is a potent reversible inhibitor of EGFRC797S with an IC50 value of 5.8 nM. JND3229 also potently suppresses EGFRL858R/T790M and EGFRWT with IC50 values of 30.5 nM and 6.8 nM, respectively. | |||||
| GC38350 | Epertinib hydrochloride | 2071195-74-7 | EGFR | ||
Epertinib hydrochloride (S-222611 hydrochloride) is a potent, orally active, reversible, and selective tyrosine kinase inhibitor of EGFR, HER2 and HER4 with IC50 of 1.48 nM, 7.15 nM and 2.49 nM, respectively. Epertinib hydrochloride (S-222611 hydrochloride) exhibits antitumor activity. | |||||
| GC13608 | Lapatinib | 231277-92-2 | Autophagy | ||
Lapatinib是一种口服的双重EGFR和HER2酪氨酸激酶抑制剂,对HER2阳性乳腺癌具有显著疗效。Lapatinib对纯化的EGFR和HER2的半数抑制浓度(IC₅₀)值分别为10.2nM和9.8nM。 | |||||
